9616309

Source:http://linkedlifedata.com/resource/pubmed/id/9616309

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010346, umls-concept:C0024501, umls-concept:C0030685, umls-concept:C0038317, umls-concept:C0054201, umls-concept:C0205263, umls-concept:C0205349, umls-concept:C0391871, umls-concept:C0442027, umls-concept:C0445550, umls-concept:C0544452, umls-concept:C0680255, umls-concept:C1257890, umls-concept:C1283071, umls-concept:C1963578, umls-concept:C2603343
pubmed:issue	4
pubmed:dateCreated	1998-6-16
pubmed:abstractText	The relapse rate after steroid induced remission in Crohn's disease is high.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-1568574, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-1679736, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-38176, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-6102739, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-6140202, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-7778826, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-7977225, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8078529, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8078530, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8161666, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8335191, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8425685, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8503403, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8536887, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8549944, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8608877, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8881815, http://linkedlifedata.com/resource/pubmed/commentcorrection/9616309-8889459
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985108R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Budesonide
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0017-5749
pubmed:author	pubmed-author:AndusTT, pubmed-author:EckerK WKW, pubmed-author:EweKK, pubmed-author:GierendMM, pubmed-author:GroteGG, pubmed-author:LoeschkeKK, pubmed-author:PlauthMM, pubmed-author:RaedlerAA, pubmed-author:RasenackJJ, pubmed-author:SchölmerichJJ, pubmed-author:WeberAA
pubmed:issnType	Print
pubmed:volume	42
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	493-6
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:9616309-Administration, Oral, pubmed-meshheading:9616309-Adolescent, pubmed-meshheading:9616309-Adult, pubmed-meshheading:9616309-Aged, pubmed-meshheading:9616309-Anti-Inflammatory Agents, pubmed-meshheading:9616309-Budesonide, pubmed-meshheading:9616309-Crohn Disease, pubmed-meshheading:9616309-Double-Blind Method, pubmed-meshheading:9616309-Drug Administration Schedule, pubmed-meshheading:9616309-Female, pubmed-meshheading:9616309-Follow-Up Studies, pubmed-meshheading:9616309-Humans, pubmed-meshheading:9616309-Male, pubmed-meshheading:9616309-Middle Aged, pubmed-meshheading:9616309-Recurrence, pubmed-meshheading:9616309-Remission Induction
pubmed:year	1998
pubmed:articleTitle	Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group.
pubmed:affiliation	Department of Internal Medicine I, University of Regensburg, Germany.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study